Novel Targeted Therapy for Low-Grade Lymphoid Malignancies in Older Adults by Dr. Krem
Dr. Krem discusses age-related and biological factors for low-grade lymphoma pathogenesis and outcomes. He then explains the mechanisms of action from low-grade lymphoma therapies. He finishes by applying recent efficacy and toxicity data to older patients with low-grade lymphoma.
Read More